Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Vitamin Shoppe, Inc. (VSI)  

NEW YORK, Aug. 29, 2017 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Vitamin Shoppe, Inc. (“Vitamin Shoppe” or the “Company”) (NYSE:VSI) in the United States District Court for the District of New Jersey on behalf of a class consisting of investors who purchased or otherwise acquired Vitamin Shoppe securities on the open market from March 1, 2017 through August 6, 2017, inclusive (the “Class Period”), seeking to recover compensable damages caused by Defendants’ violations of the Securities Exchange Act of 1934.

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) Vitamin Shoppe’s retail segment was continuing to dramatically decline; (2) its ongoing “reinvention plan” had been unsuccessful and brought more than $168 million in goodwill impairment and (3) Vitamin Shoppe was not properly recognizing that impairment charge; and (4) as a result, Defendants’ public statements were materially false and misleading at all relevant times.  When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than October 27, 2017.  A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.  If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].

Please visit our website at http://www.gme-law.com for more information about the firm.